United States
US 12,702,702 B2
Application of Caerin 1.1/1.9 combined with anti-CD47 antibody in preparing drug for treating melanoma
US 12,702,702 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Zhong’ao Biomedical Technology (Guangdong) Co., Ltd; WNL BIOMED TECH PTY. LTD. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Zhong’ao Biomedical Technology (Guangdong) Co., Ltd; WNL BIOMED TECH PTY. LTD.
- Inventors
- Xiaosong LIU; Junjie LI; Guoying NI; Tianfang WANG
- Publication date
- 2026-08-11
- Filing date
- 2025-05-22
- Document type
- B2 Granted patent
- Also written as
- US 12,702,702 B2 · US12702702 · 12702702
Abstract
The present invention belongs to the field of biotechnology, and particularly relates to an application of Caerin 1.1/1.9 combined with an anti-CD47 antibody in preparing a drug for treating melanoma. In the present invention, an amino acid sequence of the Caerin 1.1 is shown in SEQ ID NO.1; and an amino acid sequence of the Caerin 1.9 is shown in SEQ ID NO.2.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free